Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 6.98630754 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95285923 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.83175375 |
4 | vocalization behavior (GO:0071625) | 5.82414697 |
5 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.69223540 |
6 | opioid receptor signaling pathway (GO:0038003) | 5.52714433 |
7 | synaptic vesicle exocytosis (GO:0016079) | 5.51644041 |
8 | behavioral response to ethanol (GO:0048149) | 5.50449384 |
9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.47321415 |
10 | protein localization to synapse (GO:0035418) | 5.43974697 |
11 | glutamate secretion (GO:0014047) | 5.37617940 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.29571996 |
13 | neuron cell-cell adhesion (GO:0007158) | 5.26045682 |
14 | negative regulation of cAMP-mediated signaling (GO:0043951) | 5.20064146 |
15 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17247279 |
16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.08805978 |
17 | glutamate receptor signaling pathway (GO:0007215) | 4.99190475 |
18 | locomotory exploration behavior (GO:0035641) | 4.94247475 |
19 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.93592787 |
20 | synaptic vesicle maturation (GO:0016188) | 4.89037180 |
21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.86017244 |
22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.84875045 |
23 | presynaptic membrane assembly (GO:0097105) | 4.73026509 |
24 | * synaptic transmission, glutamatergic (GO:0035249) | 4.69356963 |
25 | neuronal action potential propagation (GO:0019227) | 4.67814533 |
26 | adult feeding behavior (GO:0008343) | 4.66618991 |
27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.61035085 |
28 | * neuron-neuron synaptic transmission (GO:0007270) | 4.48991614 |
29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.48873654 |
30 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.42011291 |
31 | regulation of synaptic vesicle transport (GO:1902803) | 4.41581647 |
32 | presynaptic membrane organization (GO:0097090) | 4.36533971 |
33 | postsynaptic membrane organization (GO:0001941) | 4.34352589 |
34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.33810767 |
35 | positive regulation of synapse maturation (GO:0090129) | 4.32264064 |
36 | exploration behavior (GO:0035640) | 4.30627685 |
37 | neuron recognition (GO:0008038) | 4.27115380 |
38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.17642177 |
39 | sphingoid metabolic process (GO:0046519) | 4.13662629 |
40 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.09643340 |
41 | neurotransmitter secretion (GO:0007269) | 3.98433367 |
42 | long-term memory (GO:0007616) | 3.97157200 |
43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.97002836 |
44 | sphingosine metabolic process (GO:0006670) | 3.96733194 |
45 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.95787830 |
46 | axonal fasciculation (GO:0007413) | 3.95383460 |
47 | positive regulation of membrane potential (GO:0045838) | 3.95300751 |
48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.93986262 |
49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.91669456 |
50 | long-term synaptic potentiation (GO:0060291) | 3.87527024 |
51 | regulation of synaptic plasticity (GO:0048167) | 3.84591531 |
52 | piRNA metabolic process (GO:0034587) | 3.81647824 |
53 | retinal cone cell development (GO:0046549) | 3.81348376 |
54 | synaptic vesicle endocytosis (GO:0048488) | 3.79841508 |
55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.78290544 |
56 | regulation of protein glycosylation (GO:0060049) | 3.75851776 |
57 | layer formation in cerebral cortex (GO:0021819) | 3.74151511 |
58 | transmission of nerve impulse (GO:0019226) | 3.73785538 |
59 | dendritic spine morphogenesis (GO:0060997) | 3.71755743 |
60 | regulation of neurotransmitter uptake (GO:0051580) | 3.70782716 |
61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.65835875 |
62 | regulation of synapse maturation (GO:0090128) | 3.57864999 |
63 | response to histamine (GO:0034776) | 3.55917970 |
64 | gamma-aminobutyric acid transport (GO:0015812) | 3.55714585 |
65 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.55197113 |
66 | regulation of synapse structural plasticity (GO:0051823) | 3.52830010 |
67 | regulation of dendritic spine development (GO:0060998) | 3.50733136 |
68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.50612999 |
69 | regulation of acrosome reaction (GO:0060046) | 3.49953940 |
70 | regulation of female receptivity (GO:0045924) | 3.49574969 |
71 | regulation of glutamate secretion (GO:0014048) | 3.49552533 |
72 | regulation of neurotransmitter secretion (GO:0046928) | 3.49424075 |
73 | glycosphingolipid biosynthetic process (GO:0006688) | 3.49161046 |
74 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.45656697 |
75 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.45382100 |
76 | behavioral fear response (GO:0001662) | 3.44895484 |
77 | behavioral defense response (GO:0002209) | 3.44895484 |
78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44475463 |
79 | diol metabolic process (GO:0034311) | 3.44187113 |
80 | regulation of vesicle fusion (GO:0031338) | 3.38215857 |
81 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34647448 |
82 | proline transport (GO:0015824) | 3.34110102 |
83 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33534918 |
84 | positive regulation of neurotransmitter transport (GO:0051590) | 3.32300399 |
85 | neurotransmitter transport (GO:0006836) | 3.30297192 |
86 | female mating behavior (GO:0060180) | 3.30198291 |
87 | positive regulation of dendritic spine development (GO:0060999) | 3.30158596 |
88 | long term synaptic depression (GO:0060292) | 3.29164375 |
89 | membrane depolarization (GO:0051899) | 3.26142790 |
90 | fear response (GO:0042596) | 3.23512113 |
91 | learning (GO:0007612) | 3.22965760 |
92 | cerebellar granule cell differentiation (GO:0021707) | 3.22563377 |
93 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.22529380 |
94 | cellular potassium ion homeostasis (GO:0030007) | 3.18829965 |
95 | dendritic spine organization (GO:0097061) | 3.16184115 |
96 | ether lipid metabolic process (GO:0046485) | 3.15853862 |
97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13327410 |
98 | regulation of synaptic transmission (GO:0050804) | 3.12716664 |
99 | mechanosensory behavior (GO:0007638) | 3.12188571 |
100 | startle response (GO:0001964) | 3.12070991 |
101 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11068301 |
102 | positive regulation of synaptic transmission (GO:0050806) | 3.09442063 |
103 | * synaptic transmission (GO:0007268) | 3.09323528 |
104 | glycerophospholipid catabolic process (GO:0046475) | 3.08770884 |
105 | regulation of neurotransmitter transport (GO:0051588) | 3.08662271 |
106 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06726212 |
107 | synapse assembly (GO:0007416) | 3.05721493 |
108 | negative regulation of mast cell activation (GO:0033004) | 3.05252663 |
109 | neuronal action potential (GO:0019228) | 3.04895803 |
110 | negative regulation of amino acid transport (GO:0051956) | 3.03302762 |
111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.02434611 |
112 | positive regulation of synapse assembly (GO:0051965) | 3.02413572 |
113 | regulation of neurotransmitter levels (GO:0001505) | 3.00181442 |
114 | innervation (GO:0060384) | 2.99891419 |
115 | regulation of translational termination (GO:0006449) | 2.99444641 |
116 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.98116211 |
117 | dendrite morphogenesis (GO:0048813) | 2.96075594 |
118 | detection of calcium ion (GO:0005513) | 2.95001750 |
119 | glycosphingolipid metabolic process (GO:0006687) | 2.94827839 |
120 | membrane hyperpolarization (GO:0060081) | 2.94703932 |
121 | glomerular visceral epithelial cell development (GO:0072015) | 2.94649064 |
122 | cochlea development (GO:0090102) | 2.93859090 |
123 | membrane depolarization during action potential (GO:0086010) | 2.91919815 |
124 | auditory behavior (GO:0031223) | 2.91485923 |
125 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.90542385 |
126 | synaptic vesicle transport (GO:0048489) | 2.88067463 |
127 | establishment of synaptic vesicle localization (GO:0097480) | 2.88067463 |
128 | peristalsis (GO:0030432) | 2.85621863 |
129 | cellular ketone body metabolic process (GO:0046950) | 2.84009899 |
130 | cilium morphogenesis (GO:0060271) | 2.82728745 |
131 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.82494490 |
132 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.82485163 |
133 | ganglioside metabolic process (GO:0001573) | 2.78571232 |
134 | lipopolysaccharide metabolic process (GO:0008653) | 2.74859625 |
135 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.67748142 |
136 | detection of light stimulus involved in visual perception (GO:0050908) | 2.67748142 |
137 | thrombin receptor signaling pathway (GO:0070493) | 2.67259726 |
138 | glucosamine-containing compound catabolic process (GO:1901072) | 2.64429933 |
139 | tachykinin receptor signaling pathway (GO:0007217) | 2.62081511 |
140 | phasic smooth muscle contraction (GO:0014821) | 2.60452128 |
141 | coenzyme catabolic process (GO:0009109) | 2.58209683 |
142 | regulation of cAMP-mediated signaling (GO:0043949) | 2.56823388 |
143 | ketone body metabolic process (GO:1902224) | 2.55963878 |
144 | righting reflex (GO:0060013) | 2.55263332 |
145 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.54552179 |
146 | serotonin metabolic process (GO:0042428) | 2.51002351 |
147 | sialylation (GO:0097503) | 2.50964793 |
148 | primary amino compound metabolic process (GO:1901160) | 2.50233387 |
149 | response to gravity (GO:0009629) | 2.49510441 |
150 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.46119747 |
151 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.46119747 |
152 | glomerular epithelial cell development (GO:0072310) | 2.45631960 |
153 | platelet dense granule organization (GO:0060155) | 2.43958309 |
154 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.43796571 |
155 | glycolipid metabolic process (GO:0006664) | 2.43641329 |
156 | reflex (GO:0060004) | 2.42713415 |
157 | liposaccharide metabolic process (GO:1903509) | 2.42460140 |
158 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.42382100 |
159 | protein K11-linked deubiquitination (GO:0035871) | 2.38915580 |
160 | regulation of cilium movement (GO:0003352) | 2.38875446 |
161 | rhodopsin mediated signaling pathway (GO:0016056) | 2.38339970 |
162 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.34843648 |
163 | indolalkylamine metabolic process (GO:0006586) | 2.34147358 |
164 | glycerol ether metabolic process (GO:0006662) | 2.32694755 |
165 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.32175255 |
166 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.31609906 |
167 | negative regulation of cation channel activity (GO:2001258) | 2.30066900 |
168 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.29703206 |
169 | positive regulation of meiosis (GO:0045836) | 2.29642446 |
170 | photoreceptor cell maintenance (GO:0045494) | 2.29123104 |
171 | determination of left/right symmetry (GO:0007368) | 2.29091491 |
172 | signal peptide processing (GO:0006465) | 2.28816923 |
173 | response to pheromone (GO:0019236) | 2.25801637 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.45223914 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.23570542 |
3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.25597814 |
4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16609021 |
5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16365406 |
6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04443315 |
7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70428848 |
8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61255943 |
9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61100361 |
10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60749924 |
11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60749924 |
12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58305083 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57136687 |
14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56777935 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42799043 |
16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40635461 |
17 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38787624 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37262133 |
19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21895914 |
20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16192906 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15359142 |
22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13756088 |
23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13685283 |
24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13601237 |
25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13280523 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04322593 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04076483 |
28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02106269 |
29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01490028 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01272426 |
31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97628194 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90669421 |
33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85569148 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84465410 |
35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80133410 |
36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.77608214 |
37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75917336 |
38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74992701 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64214603 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61152747 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61138110 |
42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.58197789 |
43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.58197789 |
44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56407484 |
45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52215759 |
46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52061542 |
47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50587854 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50570593 |
49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.49601094 |
50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47020659 |
51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45985188 |
52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44606152 |
53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43142086 |
54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42900993 |
55 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42021061 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41806916 |
57 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.40471455 |
58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38621656 |
59 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37594670 |
60 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.37513706 |
61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36187813 |
62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36065458 |
63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35086594 |
64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35086594 |
65 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34100089 |
66 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33199002 |
67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31382376 |
68 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.31119046 |
69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30838156 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26861243 |
71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26179278 |
72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23336704 |
73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23227881 |
74 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21195295 |
75 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20248226 |
76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19706008 |
77 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19528871 |
78 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18125164 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17683809 |
80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17336846 |
81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17275355 |
82 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17136920 |
83 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16287063 |
84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13723710 |
85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13723710 |
86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13574054 |
87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13385273 |
88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13342907 |
89 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13247863 |
90 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12977803 |
91 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12850278 |
92 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.12631734 |
93 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12546001 |
94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12343200 |
95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12310760 |
96 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12004671 |
97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10409346 |
98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10382360 |
99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10369914 |
100 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10220536 |
101 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08045518 |
102 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07937350 |
103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07530171 |
104 | * JUN_21703547_ChIP-Seq_K562_Human | 1.06465347 |
105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06330273 |
106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06246631 |
107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06186157 |
108 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06089518 |
109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06084795 |
110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05670031 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04808060 |
112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04750704 |
113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04064699 |
114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03000391 |
115 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02738699 |
116 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02580180 |
117 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02441401 |
118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02266696 |
119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01292122 |
120 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.01120109 |
121 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00833854 |
122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00328025 |
123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99986296 |
124 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99419603 |
125 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99293733 |
126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98899634 |
127 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96200316 |
128 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95803159 |
129 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95279723 |
130 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93605333 |
131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93164824 |
132 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92359459 |
133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91631598 |
134 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91244911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.56999332 |
2 | MP0003880_abnormal_central_pattern | 5.81999065 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.24203854 |
4 | MP0009745_abnormal_behavioral_response | 3.62039141 |
5 | MP0004270_analgesia | 3.54826092 |
6 | MP0002063_abnormal_learning/memory/cond | 3.49704642 |
7 | MP0001968_abnormal_touch/_nociception | 3.43434320 |
8 | MP0002064_seizures | 3.22394434 |
9 | MP0002572_abnormal_emotion/affect_behav | 2.98269704 |
10 | MP0002736_abnormal_nociception_after | 2.91329084 |
11 | MP0009046_muscle_twitch | 2.80367678 |
12 | MP0002735_abnormal_chemical_nociception | 2.77315772 |
13 | MP0002272_abnormal_nervous_system | 2.68148795 |
14 | MP0005503_abnormal_tendon_morphology | 2.59537802 |
15 | MP0001501_abnormal_sleep_pattern | 2.57245530 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.55945438 |
17 | MP0001486_abnormal_startle_reflex | 2.47819766 |
18 | MP0001440_abnormal_grooming_behavior | 2.44606996 |
19 | MP0005423_abnormal_somatic_nervous | 2.30722023 |
20 | MP0003283_abnormal_digestive_organ | 2.20410067 |
21 | MP0000778_abnormal_nervous_system | 2.07624938 |
22 | MP0002067_abnormal_sensory_capabilities | 2.07599066 |
23 | MP0009780_abnormal_chondrocyte_physiolo | 1.98020677 |
24 | MP0006276_abnormal_autonomic_nervous | 1.96324758 |
25 | MP0002733_abnormal_thermal_nociception | 1.94012017 |
26 | MP0006054_spinal_hemorrhage | 1.91838957 |
27 | MP0001970_abnormal_pain_threshold | 1.89157723 |
28 | MP0003329_amyloid_beta_deposits | 1.86441726 |
29 | MP0002184_abnormal_innervation | 1.78618279 |
30 | MP0009278_abnormal_bone_marrow | 1.78480670 |
31 | MP0002557_abnormal_social/conspecific_i | 1.73441268 |
32 | MP0003879_abnormal_hair_cell | 1.72330037 |
33 | MP0002822_catalepsy | 1.70109648 |
34 | MP0003195_calcinosis | 1.68989580 |
35 | MP0004924_abnormal_behavior | 1.65426016 |
36 | MP0005386_behavior/neurological_phenoty | 1.65426016 |
37 | MP0003950_abnormal_plasma_membrane | 1.65075939 |
38 | MP0003787_abnormal_imprinting | 1.58837632 |
39 | MP0008569_lethality_at_weaning | 1.58726573 |
40 | MP0005646_abnormal_pituitary_gland | 1.57864089 |
41 | MP0004811_abnormal_neuron_physiology | 1.54689923 |
42 | MP0003045_fibrosis | 1.54612280 |
43 | MP0003136_yellow_coat_color | 1.50369017 |
44 | MP0001188_hyperpigmentation | 1.50295294 |
45 | MP0004043_abnormal_pH_regulation | 1.50238335 |
46 | MP0002909_abnormal_adrenal_gland | 1.47046424 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.46277348 |
48 | MP0004858_abnormal_nervous_system | 1.45543892 |
49 | MP0002837_dystrophic_cardiac_calcinosis | 1.42483397 |
50 | MP0000955_abnormal_spinal_cord | 1.41855511 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.40046338 |
52 | MP0001984_abnormal_olfaction | 1.39901705 |
53 | MP0002066_abnormal_motor_capabilities/c | 1.37443498 |
54 | MP0002882_abnormal_neuron_morphology | 1.35567173 |
55 | MP0000372_irregular_coat_pigmentation | 1.34790936 |
56 | MP0001502_abnormal_circadian_rhythm | 1.34361270 |
57 | MP0002876_abnormal_thyroid_physiology | 1.34036945 |
58 | MP0001905_abnormal_dopamine_level | 1.32606641 |
59 | MP0006072_abnormal_retinal_apoptosis | 1.31687191 |
60 | MP0005257_abnormal_intraocular_pressure | 1.30680201 |
61 | MP0004885_abnormal_endolymph | 1.30134520 |
62 | MP0000681_abnormal_thyroid_gland | 1.29743837 |
63 | MP0003633_abnormal_nervous_system | 1.29015742 |
64 | MP0009764_decreased_sensitivity_to | 1.27522270 |
65 | MP0009053_abnormal_anal_canal | 1.27214963 |
66 | MP0005253_abnormal_eye_physiology | 1.23985551 |
67 | MP0001529_abnormal_vocalization | 1.18011021 |
68 | MP0010386_abnormal_urinary_bladder | 1.15227182 |
69 | MP0003183_abnormal_peptide_metabolism | 1.12634983 |
70 | MP0000749_muscle_degeneration | 1.11814136 |
71 | MP0003631_nervous_system_phenotype | 1.10333402 |
72 | MP0005187_abnormal_penis_morphology | 1.07365293 |
73 | MP0002152_abnormal_brain_morphology | 1.07168547 |
74 | MP0004145_abnormal_muscle_electrophysio | 1.06725178 |
75 | MP0004142_abnormal_muscle_tone | 1.06020085 |
76 | MP0003646_muscle_fatigue | 1.04952482 |
77 | MP0005410_abnormal_fertilization | 1.03504770 |
78 | MP0003172_abnormal_lysosome_physiology | 1.00919528 |
79 | MP0001963_abnormal_hearing_physiology | 0.98808439 |
80 | MP0004742_abnormal_vestibular_system | 0.93307228 |
81 | MP0006292_abnormal_olfactory_placode | 0.92407059 |
82 | MP0003122_maternal_imprinting | 0.92004645 |
83 | MP0008874_decreased_physiological_sensi | 0.91177307 |
84 | MP0009250_abnormal_appendicular_skeleto | 0.90477767 |
85 | MP0005195_abnormal_posterior_eye | 0.90267070 |
86 | MP0004484_altered_response_of | 0.90234052 |
87 | MP0005551_abnormal_eye_electrophysiolog | 0.90192084 |
88 | MP0002069_abnormal_eating/drinking_beha | 0.89453069 |
89 | MP0005171_absent_coat_pigmentation | 0.87131430 |
90 | MP0003191_abnormal_cellular_cholesterol | 0.86713014 |
91 | MP0008872_abnormal_physiological_respon | 0.86230792 |
92 | MP0008877_abnormal_DNA_methylation | 0.85588688 |
93 | MP0001177_atelectasis | 0.85250744 |
94 | MP0002653_abnormal_ependyma_morphology | 0.84984317 |
95 | MP0002168_other_aberrant_phenotype | 0.84484688 |
96 | MP0003937_abnormal_limbs/digits/tail_de | 0.83610991 |
97 | MP0005508_abnormal_skeleton_morphology | 0.83568201 |
98 | MP0002229_neurodegeneration | 0.83529391 |
99 | MP0001986_abnormal_taste_sensitivity | 0.83112871 |
100 | MP0000569_abnormal_digit_pigmentation | 0.81193669 |
101 | MP0000751_myopathy | 0.80980578 |
102 | MP0000604_amyloidosis | 0.80930906 |
103 | MP0002102_abnormal_ear_morphology | 0.80778697 |
104 | MP0004085_abnormal_heartbeat | 0.80430795 |
105 | MP0005409_darkened_coat_color | 0.79423511 |
106 | MP0000358_abnormal_cell_content/ | 0.78861146 |
107 | MP0002090_abnormal_vision | 0.77543452 |
108 | MP0004215_abnormal_myocardial_fiber | 0.77507687 |
109 | MP0000631_abnormal_neuroendocrine_gland | 0.77442493 |
110 | MP0002752_abnormal_somatic_nervous | 0.74953401 |
111 | MP0005174_abnormal_tail_pigmentation | 0.74409415 |
112 | MP0005535_abnormal_body_temperature | 0.73284962 |
113 | MP0008775_abnormal_heart_ventricle | 0.73218028 |
114 | MP0000516_abnormal_urinary_system | 0.73147817 |
115 | MP0005367_renal/urinary_system_phenotyp | 0.73147817 |
116 | MP0000230_abnormal_systemic_arterial | 0.72247180 |
117 | MP0003632_abnormal_nervous_system | 0.71692970 |
118 | MP0005310_abnormal_salivary_gland | 0.71523346 |
119 | MP0001664_abnormal_digestion | 0.71232756 |
120 | MP0003638_abnormal_response/metabolism_ | 0.71205353 |
121 | MP0004510_myositis | 0.70523558 |
122 | MP0003075_altered_response_to | 0.70092534 |
123 | MP0000026_abnormal_inner_ear | 0.68830252 |
124 | MP0004272_abnormal_basement_membrane | 0.68557637 |
125 | MP0008438_abnormal_cutaneous_collagen | 0.67412835 |
126 | MP0001485_abnormal_pinna_reflex | 0.64356609 |
127 | MP0002638_abnormal_pupillary_reflex | 0.61156208 |
128 | MP0003634_abnormal_glial_cell | 0.60599869 |
129 | MP0005394_taste/olfaction_phenotype | 0.60127385 |
130 | MP0005499_abnormal_olfactory_system | 0.60127385 |
131 | MP0000920_abnormal_myelination | 0.59977080 |
132 | MP0003938_abnormal_ear_development | 0.59762826 |
133 | MP0000015_abnormal_ear_pigmentation | 0.59360237 |
134 | MP0003690_abnormal_glial_cell | 0.55690276 |
135 | MP0003861_abnormal_nervous_system | 0.54336082 |
136 | MP0001943_abnormal_respiration | 0.51616548 |
137 | MP0003137_abnormal_impulse_conducting | 0.50400452 |
138 | MP0010769_abnormal_survival | 0.50081200 |
139 | MP0010770_preweaning_lethality | 0.49781155 |
140 | MP0002082_postnatal_lethality | 0.49781155 |
141 | MP0005623_abnormal_meninges_morphology | 0.47657604 |
142 | MP0010768_mortality/aging | 0.47425915 |
143 | MP0000013_abnormal_adipose_tissue | 0.47116739 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.60158363 |
2 | Thyroid-stimulating hormone excess (HP:0002925) | 6.22980122 |
3 | Focal seizures (HP:0007359) | 6.18552114 |
4 | Myokymia (HP:0002411) | 6.12629388 |
5 | Epileptic encephalopathy (HP:0200134) | 6.10750538 |
6 | Visual hallucinations (HP:0002367) | 5.64383955 |
7 | Atonic seizures (HP:0010819) | 5.54242778 |
8 | Hyperventilation (HP:0002883) | 5.48295254 |
9 | Febrile seizures (HP:0002373) | 5.38263198 |
10 | Absence seizures (HP:0002121) | 4.61676479 |
11 | Broad-based gait (HP:0002136) | 4.42044600 |
12 | Dialeptic seizures (HP:0011146) | 4.37676411 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 4.25412251 |
14 | Intestinal atresia (HP:0011100) | 4.08344543 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.00588180 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.00588180 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.00588180 |
18 | Progressive cerebellar ataxia (HP:0002073) | 3.98775305 |
19 | Large for gestational age (HP:0001520) | 3.58416012 |
20 | Poor eye contact (HP:0000817) | 3.53252761 |
21 | Excessive salivation (HP:0003781) | 3.44205017 |
22 | Drooling (HP:0002307) | 3.44205017 |
23 | Gaze-evoked nystagmus (HP:0000640) | 3.44129370 |
24 | Amblyopia (HP:0000646) | 3.43549325 |
25 | Poor head control (HP:0002421) | 3.41199636 |
26 | Agitation (HP:0000713) | 3.35264617 |
27 | Mesangial abnormality (HP:0001966) | 3.25376002 |
28 | Cerebral inclusion bodies (HP:0100314) | 3.20551177 |
29 | Absent speech (HP:0001344) | 3.11251819 |
30 | Type II lissencephaly (HP:0007260) | 3.09509023 |
31 | Protruding tongue (HP:0010808) | 3.08644297 |
32 | Abnormal social behavior (HP:0012433) | 3.02630041 |
33 | Impaired social interactions (HP:0000735) | 3.02630041 |
34 | Cerebellar dysplasia (HP:0007033) | 3.00017287 |
35 | Supranuclear gaze palsy (HP:0000605) | 2.99162845 |
36 | Epileptiform EEG discharges (HP:0011182) | 2.97772624 |
37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.95684711 |
38 | Dysdiadochokinesis (HP:0002075) | 2.93092487 |
39 | Truncal ataxia (HP:0002078) | 2.86646829 |
40 | Dysmetria (HP:0001310) | 2.85650225 |
41 | Diplopia (HP:0000651) | 2.85278327 |
42 | Abnormality of binocular vision (HP:0011514) | 2.85278327 |
43 | Inability to walk (HP:0002540) | 2.81605762 |
44 | Abnormality of midbrain morphology (HP:0002418) | 2.79123263 |
45 | Molar tooth sign on MRI (HP:0002419) | 2.79123263 |
46 | Neurofibrillary tangles (HP:0002185) | 2.74353652 |
47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.72957109 |
48 | Dysostosis multiplex (HP:0000943) | 2.72288421 |
49 | Fetal akinesia sequence (HP:0001989) | 2.71691753 |
50 | Action tremor (HP:0002345) | 2.71006491 |
51 | Congenital stationary night blindness (HP:0007642) | 2.70383145 |
52 | Volvulus (HP:0002580) | 2.69348407 |
53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.69068937 |
54 | Anxiety (HP:0000739) | 2.68374955 |
55 | Depression (HP:0000716) | 2.67668487 |
56 | Disproportionate short-trunk short stature (HP:0003521) | 2.66744591 |
57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66010841 |
58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66010841 |
59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66010841 |
60 | Hemiparesis (HP:0001269) | 2.65713942 |
61 | Limb dystonia (HP:0002451) | 2.60998810 |
62 | Severe visual impairment (HP:0001141) | 2.59390446 |
63 | Impaired smooth pursuit (HP:0007772) | 2.59070786 |
64 | Abnormal eating behavior (HP:0100738) | 2.55941704 |
65 | Pancreatic cysts (HP:0001737) | 2.55934557 |
66 | Keratoconus (HP:0000563) | 2.53373395 |
67 | Increased corneal curvature (HP:0100692) | 2.53373395 |
68 | Abnormality of the lower motor neuron (HP:0002366) | 2.52299405 |
69 | 3-Methylglutaconic aciduria (HP:0003535) | 2.50760518 |
70 | Stereotypic behavior (HP:0000733) | 2.50578673 |
71 | Attenuation of retinal blood vessels (HP:0007843) | 2.49692966 |
72 | Abnormality of the aortic arch (HP:0012303) | 2.46323603 |
73 | Hypsarrhythmia (HP:0002521) | 2.45067147 |
74 | Tubular atrophy (HP:0000092) | 2.40406791 |
75 | Abnormality of salivation (HP:0100755) | 2.39530895 |
76 | Blue irides (HP:0000635) | 2.39360459 |
77 | Upper limb muscle weakness (HP:0003484) | 2.37175494 |
78 | Ankle clonus (HP:0011448) | 2.36481320 |
79 | True hermaphroditism (HP:0010459) | 2.36152837 |
80 | Mutism (HP:0002300) | 2.36144779 |
81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34619453 |
82 | Generalized myoclonic seizures (HP:0002123) | 2.34085012 |
83 | Polyphagia (HP:0002591) | 2.33544142 |
84 | Postural instability (HP:0002172) | 2.30679973 |
85 | Fair hair (HP:0002286) | 2.30434780 |
86 | Hypothermia (HP:0002045) | 2.28505317 |
87 | Large eyes (HP:0001090) | 2.28013939 |
88 | Progressive inability to walk (HP:0002505) | 2.27256317 |
89 | Pancreatic fibrosis (HP:0100732) | 2.26744235 |
90 | Status epilepticus (HP:0002133) | 2.25707503 |
91 | Generalized hypopigmentation of hair (HP:0011358) | 2.25375067 |
92 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.24686178 |
93 | Scanning speech (HP:0002168) | 2.24637544 |
94 | Genetic anticipation (HP:0003743) | 2.24623737 |
95 | Delusions (HP:0000746) | 2.24322813 |
96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23168081 |
97 | Mucopolysacchariduria (HP:0008155) | 2.23168081 |
98 | Inappropriate behavior (HP:0000719) | 2.22391252 |
99 | Thickened helices (HP:0000391) | 2.22318563 |
100 | Spastic gait (HP:0002064) | 2.21711367 |
101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.20931092 |
102 | Absent/shortened dynein arms (HP:0200106) | 2.20931092 |
103 | Follicular hyperkeratosis (HP:0007502) | 2.19458244 |
104 | Bradykinesia (HP:0002067) | 2.19275171 |
105 | Urinary urgency (HP:0000012) | 2.16659137 |
106 | Medial flaring of the eyebrow (HP:0010747) | 2.15551244 |
107 | Papilledema (HP:0001085) | 2.14292803 |
108 | Nephronophthisis (HP:0000090) | 2.13747148 |
109 | Gastrointestinal atresia (HP:0002589) | 2.13212244 |
110 | Increased cerebral lipofuscin (HP:0011813) | 2.11087383 |
111 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10718579 |
112 | Impaired vibratory sensation (HP:0002495) | 2.07619254 |
113 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07167837 |
114 | Widely spaced teeth (HP:0000687) | 2.05481535 |
115 | Abnormality of the corticospinal tract (HP:0002492) | 2.05315914 |
116 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.04606032 |
117 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04044715 |
118 | Tented upper lip vermilion (HP:0010804) | 2.03903016 |
119 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03720358 |
120 | Insidious onset (HP:0003587) | 2.01195238 |
121 | Termporal pattern (HP:0011008) | 2.01195238 |
122 | Vacuolated lymphocytes (HP:0001922) | 2.00728183 |
123 | Optic nerve hypoplasia (HP:0000609) | 1.99768991 |
124 | Abnormality of macular pigmentation (HP:0008002) | 1.98246393 |
125 | Exotropia (HP:0000577) | 1.97938188 |
126 | Obstructive sleep apnea (HP:0002870) | 1.97666915 |
127 | Gait imbalance (HP:0002141) | 1.96373807 |
128 | Abnormality of the vitreous humor (HP:0004327) | 1.94814885 |
129 | Retinal dysplasia (HP:0007973) | 1.94497458 |
130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91563511 |
131 | Gait ataxia (HP:0002066) | 1.91389122 |
132 | Hyperthyroidism (HP:0000836) | 1.88820927 |
133 | Akinesia (HP:0002304) | 1.88556896 |
134 | Lissencephaly (HP:0001339) | 1.88391088 |
135 | Severe muscular hypotonia (HP:0006829) | 1.87583959 |
136 | Lower limb muscle weakness (HP:0007340) | 1.87015290 |
137 | Abnormal drinking behavior (HP:0030082) | 1.86264271 |
138 | Polydipsia (HP:0001959) | 1.86264271 |
139 | Congenital primary aphakia (HP:0007707) | 1.85655024 |
140 | Hemiplegia (HP:0002301) | 1.84624895 |
141 | Clumsiness (HP:0002312) | 1.84155034 |
142 | Incomplete penetrance (HP:0003829) | 1.83585024 |
143 | Sclerocornea (HP:0000647) | 1.83074684 |
144 | Abnormality of the renal medulla (HP:0100957) | 1.81826064 |
145 | Megalencephaly (HP:0001355) | 1.81370455 |
146 | Gastroesophageal reflux (HP:0002020) | 1.80650920 |
147 | Torticollis (HP:0000473) | 1.79704350 |
148 | Hand muscle atrophy (HP:0009130) | 1.79395954 |
149 | Intention tremor (HP:0002080) | 1.79209365 |
150 | Intellectual disability, severe (HP:0010864) | 1.79075896 |
151 | Increased CSF protein (HP:0002922) | 1.78461164 |
152 | Psychosis (HP:0000709) | 1.77554350 |
153 | Sleep apnea (HP:0010535) | 1.77212613 |
154 | Focal dystonia (HP:0004373) | 1.77065292 |
155 | Neonatal respiratory distress (HP:0002643) | 1.75796191 |
156 | Abnormal ciliary motility (HP:0012262) | 1.75558408 |
157 | Absent frontal sinuses (HP:0002688) | 1.75449099 |
158 | Dysmetric saccades (HP:0000641) | 1.74531927 |
159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71823238 |
160 | Esotropia (HP:0000565) | 1.68264101 |
161 | Abnormal hair whorl (HP:0010721) | 1.68196769 |
162 | Specific learning disability (HP:0001328) | 1.66774712 |
163 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66425556 |
164 | Metaphyseal dysplasia (HP:0100255) | 1.66292775 |
165 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.65514747 |
166 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.65514747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 6.39607755 |
2 | ADRBK2 | 6.29528350 |
3 | EPHA4 | 5.38595610 |
4 | NTRK3 | 4.64810291 |
5 | CASK | 3.82777804 |
6 | MAP3K9 | 3.25161242 |
7 | MAP3K4 | 2.96140806 |
8 | MAP2K7 | 2.94425027 |
9 | DAPK2 | 2.77736252 |
10 | MARK1 | 2.66001206 |
11 | RIPK4 | 2.47978537 |
12 | WNK3 | 2.47889393 |
13 | BMPR1B | 2.40978735 |
14 | MAP3K12 | 2.35603403 |
15 | MINK1 | 2.33395862 |
16 | ACVR1B | 2.29590128 |
17 | MAP2K4 | 2.11421858 |
18 | PLK2 | 2.09658897 |
19 | TNIK | 2.02489863 |
20 | DAPK1 | 1.97681571 |
21 | GRK1 | 1.80146175 |
22 | STK38L | 1.78897565 |
23 | CDK19 | 1.78522000 |
24 | NTRK2 | 1.73835396 |
25 | PRPF4B | 1.71321746 |
26 | PNCK | 1.63362930 |
27 | IRAK3 | 1.61865977 |
28 | PAK6 | 1.59912901 |
29 | GRK5 | 1.58516114 |
30 | KSR2 | 1.54860665 |
31 | KSR1 | 1.51852570 |
32 | MAPK13 | 1.47823181 |
33 | LIMK1 | 1.47787236 |
34 | SIK2 | 1.43598933 |
35 | FES | 1.42922491 |
36 | MAP3K13 | 1.42699133 |
37 | CDK5 | 1.38167903 |
38 | LMTK2 | 1.32790911 |
39 | CSNK1G3 | 1.27815814 |
40 | BMPR2 | 1.27475305 |
41 | NTRK1 | 1.26682941 |
42 | ARAF | 1.25225139 |
43 | CAMKK1 | 1.25192485 |
44 | CSNK1A1L | 1.24539652 |
45 | PTK2B | 1.23502868 |
46 | PRKCG | 1.22254617 |
47 | CAMK2A | 1.16290506 |
48 | CSNK1G1 | 1.15705262 |
49 | MAP4K2 | 1.15251770 |
50 | ERBB4 | 1.13493629 |
51 | INSRR | 1.06683713 |
52 | OXSR1 | 1.05877059 |
53 | PRKD3 | 1.04541102 |
54 | CCNB1 | 1.03931168 |
55 | ZAK | 1.01224893 |
56 | FGR | 1.01091880 |
57 | CAMK2B | 0.98723499 |
58 | WNK4 | 0.95085954 |
59 | MKNK2 | 0.94754489 |
60 | NME1 | 0.91808310 |
61 | MAP3K6 | 0.88733471 |
62 | MUSK | 0.88591020 |
63 | CAMK1 | 0.87594587 |
64 | DYRK1A | 0.85167628 |
65 | STK24 | 0.83601989 |
66 | EIF2AK3 | 0.83215142 |
67 | NEK9 | 0.82358475 |
68 | UHMK1 | 0.79454820 |
69 | MAP3K2 | 0.77917228 |
70 | AKT3 | 0.77882150 |
71 | RAF1 | 0.76433173 |
72 | CDK18 | 0.75427819 |
73 | CAMKK2 | 0.75341555 |
74 | STK38 | 0.74635145 |
75 | PRKD2 | 0.73382030 |
76 | SGK494 | 0.72624422 |
77 | SGK223 | 0.72624422 |
78 | CDK14 | 0.72072113 |
79 | TGFBR1 | 0.71822886 |
80 | CDK15 | 0.71523657 |
81 | CAMK1G | 0.69813924 |
82 | STK11 | 0.69276877 |
83 | MAPKAPK5 | 0.68463466 |
84 | SGK1 | 0.68361118 |
85 | PRKCE | 0.64378774 |
86 | SIK3 | 0.63497514 |
87 | FER | 0.62394037 |
88 | STK39 | 0.61898846 |
89 | CDK11A | 0.61191972 |
90 | SGK2 | 0.60744400 |
91 | TYRO3 | 0.60091428 |
92 | MAPKAPK3 | 0.59960288 |
93 | LATS2 | 0.58985697 |
94 | ABL2 | 0.56391566 |
95 | PHKG1 | 0.55551243 |
96 | PHKG2 | 0.55551243 |
97 | MAP2K6 | 0.55394669 |
98 | CAMK2D | 0.54609023 |
99 | TESK1 | 0.53060486 |
100 | MARK2 | 0.51456455 |
101 | PAK3 | 0.50903561 |
102 | MAPK11 | 0.50805974 |
103 | MAPK12 | 0.50736023 |
104 | BCKDK | 0.49909265 |
105 | CSNK1G2 | 0.49605081 |
106 | PDK1 | 0.49603660 |
107 | BRAF | 0.47633728 |
108 | PDPK1 | 0.47221145 |
109 | GRK6 | 0.46834255 |
110 | GRK7 | 0.46508957 |
111 | PRKCZ | 0.46084266 |
112 | ROCK1 | 0.45320095 |
113 | TRPM7 | 0.45107570 |
114 | DAPK3 | 0.44995668 |
115 | CDK3 | 0.43116173 |
116 | RET | 0.42313114 |
117 | EIF2AK1 | 0.41307395 |
118 | PINK1 | 0.40281219 |
119 | PRKCI | 0.40081684 |
120 | PRKG1 | 0.39715071 |
121 | CAMK2G | 0.37764973 |
122 | PRKCH | 0.37596050 |
123 | NEK6 | 0.37124560 |
124 | ERN1 | 0.36368920 |
125 | MAP3K7 | 0.36358860 |
126 | MOS | 0.35716956 |
127 | LATS1 | 0.35392459 |
128 | FYN | 0.34617980 |
129 | RPS6KA3 | 0.33784570 |
130 | ERBB3 | 0.32802684 |
131 | ROCK2 | 0.32463787 |
132 | GSK3A | 0.32419204 |
133 | MAP3K1 | 0.32049239 |
134 | BCR | 0.32003829 |
135 | SGK3 | 0.31755911 |
136 | MAP2K1 | 0.31666874 |
137 | PRKCA | 0.31541545 |
138 | FGFR2 | 0.31425913 |
139 | TNK2 | 0.31366251 |
140 | CSNK1A1 | 0.31134486 |
141 | MAPK10 | 0.30665407 |
142 | PKN1 | 0.30435723 |
143 | PTK2 | 0.30251172 |
144 | PRKCB | 0.30163442 |
145 | MAP3K3 | 0.30102889 |
146 | CAMK4 | 0.30089442 |
147 | ADRBK1 | 0.29165973 |
148 | DMPK | 0.28864890 |
149 | PRKACA | 0.28720900 |
150 | STK3 | 0.25778238 |
151 | ABL1 | 0.25141700 |
152 | CSNK1D | 0.23999785 |
153 | FLT3 | 0.23878238 |
154 | MET | 0.22433562 |
155 | PRKACB | 0.21214382 |
156 | PIM2 | 0.21100135 |
157 | CAMK1D | 0.20911161 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.39071948 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.32305255 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.04584794 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.98364404 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.84245255 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.81416818 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67727570 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.66874943 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.66063960 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.61216483 |
11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51012408 |
12 | Taste transduction_Homo sapiens_hsa04742 | 2.20860077 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19789754 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 2.17476890 |
15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10462198 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 2.00053465 |
17 | Lysosome_Homo sapiens_hsa04142 | 1.99513134 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97308627 |
19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95114449 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92874411 |
21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87627464 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.82294725 |
23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.82211003 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81199248 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.80856366 |
26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80537199 |
27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79008518 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.75368403 |
29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73012553 |
30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.69519203 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66154103 |
32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.65527290 |
33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50457627 |
34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45661020 |
35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40108472 |
36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37135032 |
37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36150042 |
38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31750842 |
39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31668475 |
40 | Axon guidance_Homo sapiens_hsa04360 | 1.28305283 |
41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27558820 |
42 | Gap junction_Homo sapiens_hsa04540 | 1.22388649 |
43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16287086 |
44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12337881 |
45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10139839 |
46 | Mineral absorption_Homo sapiens_hsa04978 | 1.09962678 |
47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06715657 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.06520250 |
49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03857473 |
50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03828155 |
51 | Glioma_Homo sapiens_hsa05214 | 1.03422366 |
52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03393762 |
53 | Melanogenesis_Homo sapiens_hsa04916 | 1.03066611 |
54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02048745 |
55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99877779 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99867801 |
57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99327288 |
58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98676797 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93782523 |
60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92484159 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90649211 |
62 | Phototransduction_Homo sapiens_hsa04744 | 0.88553910 |
63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81322657 |
64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79138535 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78655167 |
66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77108967 |
67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77105619 |
68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76335096 |
69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74325603 |
70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74257395 |
71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73369907 |
72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70365004 |
73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69997585 |
74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69918169 |
75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69628233 |
76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69397106 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65385616 |
78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65367473 |
79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64382619 |
80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63121768 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62886234 |
82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62605036 |
83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61780326 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61641135 |
85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61314074 |
86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61001134 |
87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60239750 |
88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60101384 |
89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60001332 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59757866 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58918028 |
92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58629571 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58457776 |
94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58309985 |
95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55625662 |
96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54989460 |
97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53595499 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52447208 |
99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51496380 |
100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51403091 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50770191 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48520443 |
103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.48319952 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48052446 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47943842 |
106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47814737 |
107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46814606 |
108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45426098 |
109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45353497 |
110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45182926 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41292915 |
112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39691922 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38720518 |
114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37917519 |
115 | Prion diseases_Homo sapiens_hsa05020 | 0.37831942 |
116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37803228 |
117 | Peroxisome_Homo sapiens_hsa04146 | 0.36473375 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36418825 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35340850 |
120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33559923 |
121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33355837 |
122 | Alcoholism_Homo sapiens_hsa05034 | 0.33038126 |
123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32025341 |
124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30979588 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30713721 |
126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30338518 |
127 | Phagosome_Homo sapiens_hsa04145 | 0.29919709 |
128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29196331 |
129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29078804 |
130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27153130 |
131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27001599 |
132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26944779 |
133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26671668 |
134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25823319 |
135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25537359 |
136 | Focal adhesion_Homo sapiens_hsa04510 | 0.24199018 |
137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23265853 |
138 | Bile secretion_Homo sapiens_hsa04976 | 0.22799660 |
139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22555349 |
140 | Endocytosis_Homo sapiens_hsa04144 | 0.22261686 |
141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21974952 |
142 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20844722 |
143 | Parkinsons disease_Homo sapiens_hsa05012 | 0.20815337 |